Ofatumumab

Reactant for preparation of: . Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP . Cytotoxic and antimitotic agents . Insulin-like growth factor 1 receptor inhibitors . Antitumoral agents . Factor Xa inhibitor . Potential

Reactant for preparation of: . Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP . Cytotoxic and antimitotic agents . Insulin-like growth factor 1 receptor inhibitors . Antitumoral agents . Factor Xa inhibitor . Potential

Reactant for preparation of: . Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP . Cytotoxic and antimitotic agents . Insulin-like growth factor 1 receptor inhibitors . Antitumoral agents . Factor Xa inhibitor . Potential

Reactant for preparation of: . Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP . Cytotoxic and antimitotic agents . Insulin-like growth factor 1 receptor inhibitors . Antitumoral agents . Factor Xa inhibitor . Potential

A minor, bioactive component of ginger with anti-inflammatory and anticancer properties induces apoptosis in cancer cells through the production of reactive oxygen species and the activation of caspase, impairs tubulin polymerization, downregulates

A minor, bioactive component of ginger with anti-inflammatory and anticancer properties induces apoptosis in cancer cells through the production of reactive oxygen species and the activation of caspase, impairs tubulin polymerization, downregulates

A minor, bioactive component of ginger with anti-inflammatory and anticancer properties induces apoptosis in cancer cells through the production of reactive oxygen species and the activation of caspase, impairs tubulin polymerization, downregulates

7,8-Dihydroxy-4-methylcoumarin.

7,8-Dihydroxy-4-methylcoumarin.

7,8-Dihydroxy-4-methylcoumarin.

7,8-Dihydroxy-4-methylcoumarin.

7,8-Dihydroxy-4-methylcoumarin.